Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation. Galeone A, Salem JE, Lebreton G, Coutance G, et al. Clin Transplant 2022 Feb 21:e14616. doi: 10.1111/ctr.14616.

Read + Share

Amedeo Smart

Independent Medical Education

Galeone A, Salem JE, Lebreton G, Coutance G, et al. Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation. Clin Transplant 2022 Feb 21:e14616. doi: 10.1111/ctr.14616.
PMID: 35188995